Clinical Trial Update: Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of risedronate and parathyroid hormone for male osteoporosis has completed and results have been posted. The study in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Teriparatide (Teriparatide)
• risedronate (risedronate)

Snippet

Sponsor: Columbia University | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2014-03-04